Literature DB >> 4629844

Malignant lymphoma induced by partially purified Herpesvirus saimiri and recovery of infectious virus from tumorous lymph nodes.

R Laufs, B Fleckenstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4629844     DOI: 10.1007/bf02120479

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  12 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  Demonstration of Herpesvirus saimiri-associated antigens in peripheral lymphocytes from infected marmosets during in vitro cultivation.

Authors:  L A Falk; L G Wolfe; J Hoekstra; F Deinhardt
Journal:  J Natl Cancer Inst       Date:  1972-02       Impact factor: 13.506

3.  Lymphoid cell-culture line derived from lymph node of marmoset infected wtih Herpesvirus saimiri--preliminary report.

Authors:  A S Rabson; G T O'Conor; D E Lorenz; R L Kirschstein; F Y Legallais; T S Tralka
Journal:  J Natl Cancer Inst       Date:  1971-05       Impact factor: 13.506

4.  Morphological confirmation of the herpes nature of a carcinogenic virus of primates (Herpes saimiri).

Authors:  D G Morgan; M A Epstein; B G Achong; L V Meléndez
Journal:  Nature       Date:  1970-10-10       Impact factor: 49.962

5.  Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells.

Authors:  H Zur Hausen; H Schulte-Holthausen
Journal:  Nature       Date:  1970-07-18       Impact factor: 49.962

6.  The effect of polyinosinic: polycytidylic acid on fluorescent and neutralizing antibodies to Herpesvirus saimiri in goats.

Authors:  C E Fraser; L V Meléndez; H H Barahona; M D Daniel
Journal:  Int J Cancer       Date:  1971-05-15       Impact factor: 7.396

7.  Herpesvirus saimiri. II. Experimentally induced malignant lymphoma in primates.

Authors:  L V Meléndez; R D Hunt; M D Daniel; F G García; C E Fraser
Journal:  Lab Anim Care       Date:  1969-06

8.  Oncogenicity of herpesvirus saimiri in marmoset monkeys.

Authors:  L G Wolfe; L A Falk; F Deinhardt
Journal:  J Natl Cancer Inst       Date:  1971-11       Impact factor: 13.506

9.  Herpesvirus Saimiri induced malignant lymphoma: recovery of the viral agent from the fatally affected animals.

Authors:  L V Meléndez; M D Daniel; R D Hunt
Journal:  Bibl Haematol       Date:  1970

10.  Herpesvirus saimiri. 3. Plaque formation under multi agar, methyl cellulose and starch overlays.

Authors:  M D Daniel; H Rabin; H H Barahona; L V Meléndez
Journal:  Proc Soc Exp Biol Med       Date:  1971-04
View more
  6 in total

1.  Herpesvirus ateles DNA and its homology with Herpesvirus saimiri nucleic acid.

Authors:  B Fleckenstein; G W Bornkamm; C Mulder; F J Werner; M D Daniel; L A Falk; H Delius
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

2.  Latent infection of monkeys with oncogenic herpes viruses.

Authors:  R Laufs; L V Meléndez
Journal:  Med Microbiol Immunol       Date:  1973       Impact factor: 3.402

3.  Susceptibility to Herpesvirus saimiri and antibody development in old and new world monkeys.

Authors:  R Laufs; B Fleckenstein
Journal:  Med Microbiol Immunol       Date:  1973-03-08       Impact factor: 3.402

4.  Repetitive sequences in complete and defective genomes of Herpesvirus saimiri.

Authors:  B Fleckenstein; G W Bornkamm; H Ludwig
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

5.  Stimulation of Herpesvirus saimiri expression in the absence of evidence for type C virus activation in a marmoset lymphoid cell line.

Authors:  R H Neubauer; W C Wallen; H Rabin
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

6.  Biographical Feature: Bernhard Fleckenstein.

Authors:  Andrea K Thoma-Kress; Ronald C Desrosiers; Michaela U Gack; Jae U Jung; Klaus Überla; Frank Kirchhoff
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.